Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

322
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
322
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

631
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
631
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

315
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
315
Drug Therapy01:28

Drug Therapy

156
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
156
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

543
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
543
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

524
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
524

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trajectories of gray and white matter volume in children at elevated risk for schizophrenia.

CNS spectrums·2026
Same author

How deaths of despair shape life expectancy across sexes and regions in Sweden.

Scandinavian journal of public health·2026
Same author

Changes in insight and outcome over the early course of first-episode psychosis. The OPTiMiSE trial.

Schizophrenia research. Cognition·2026
Same author

Generalizability of findings from neurobiological studies of individuals with first-episode psychosis: a cohort study.

Schizophrenia (Heidelberg, Germany)·2026
Same author

Aetiological factors in functional seizures and functional motor symptoms: shared and distinct features.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Increased Brain-Age Gap in Young Adults With Psychotic Experiences.

Biological psychiatry global open science·2026

Related Experiment Video

Updated: Nov 24, 2025

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
07:35

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

11.8K

Clozapine Response in Schizophrenia and Hematological Changes.

Graham Blackman, Jenny E L Lisshammar, Rayyan Zafar1

  • 1Centre for Neuropsychopharmacology, Imperial College London Trust.

Journal of Clinical Psychopharmacology
|December 21, 2020
PubMed
Summary

Clozapine treatment for schizophrenia causes temporary changes in blood cell counts. These hematological changes, however, do not predict treatment response in patients with treatment-resistant schizophrenia.

More Related Videos

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

468
Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
12:00

Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization

Published on: November 19, 2014

13.1K

Related Experiment Videos

Last Updated: Nov 24, 2025

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
07:35

Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans

Published on: February 4, 2014

11.8K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

468
Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
12:00

Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization

Published on: November 19, 2014

13.1K

Area of Science:

  • Psychiatry
  • Hematology
  • Pharmacology

Background:

  • Clozapine is a crucial treatment for treatment-resistant schizophrenia.
  • Its precise mechanism of action is not fully understood.
  • This study investigates a potential link between hematological changes and clozapine's effectiveness.

Purpose of the Study:

  • To determine if clozapine's efficacy in treatment-resistant schizophrenia correlates with hematological measure alterations.
  • To analyze changes in white blood cell, neutrophil, and platelet counts post-clozapine initiation.

Main Methods:

  • Retrospective analysis of electronic patient records from a large UK mental health trust (n=188).
  • Assessment of hematological data (white blood cell, neutrophil, platelet counts) at baseline and during early clozapine treatment.
  • Treatment response defined by Clinical Global Impression-Improvement (CGI-I) at 3 months.

Main Results:

  • Clozapine initiation led to significant, transient increases in white blood cell, neutrophil, and platelet counts (peaking at weeks 3-4).
  • 59.6% of patients (n=112) responded to clozapine treatment.
  • No significant association was found between baseline hematological factors or their changes and treatment response.

Conclusions:

  • Clozapine treatment induces temporary hematological shifts within the first month.
  • These observed hematological changes are not indicative of therapeutic response in patients with treatment-resistant schizophrenia.